Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • CONGRESSIONAL RATINGS
        • PORKER OF THE MONTH
        • PRESS RELEASES
        • COMMENTARY
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • Earmark Database
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Pharmaceuticals

General Waste, Healthcare, Intellectual Property, Medicare, Pharmaceuticals

Biden Price Controls Kill Innovation and Patients

October 6, 2023 Christina Smith

 IRA drug price controls will devastate future drug development, resulting in more lives lost.

General Waste, Healthcare, Medicare, Pharmaceuticals

Congress Should not Double Down on Devastating Drug Price Controls

August 1, 2023 Christina Smith

House Democrats’ new bill on price controls will devastate future drug development and raise costs. 

Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, Pharmaceuticals, Regulations

Biden’s Budget and the SMART Prices Act Will Devastate Drug Development

June 24, 2023 Thomas Schatz

Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.

General Waste, Healthcare, Pharmaceuticals

Patients Pay the Ultimate Price for Price Controls

February 17, 2023 Christina Smith

Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices. 

The Senate Should Not Implement Price Controls on Pharmaceuticals
Big Government, Biopharmaceuticals, CMS, General Waste, Government Waste, Healthcare, Medicare, Medicare/aid, Pharmaceuticals

The Senate Should Not Implement Price Controls on Pharmaceuticals

July 1, 2022 Christina Smith

Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures. 

Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, Pharmaceuticals, Property Rights

Sen. Elizabeth Warren Wants the Government to Steal IP and Stifle Future Pharmaceutical Innovation

April 27, 2022 Christina Smith

Sen. Elizabeth Warren (D-Mass.) urges HHS to steal and redistribute intellectual property as a mechanism to lower drug prices.

Big Government, Biopharmaceuticals, Biosimilars, General Waste, Government Waste, Healthcare, Medicare, Medicare/aid, Pharmaceuticals

Price Controls in the BBBA Will Destroy the Development of Future Cures

January 29, 2022 Christina Smith

The price controls found in the BBBA leave patients worse off.

Budget, CMS, General Waste, Healthcare, Medicaid, Medicare/aid, Pharmaceuticals, Taxes

The Resurgence of the Build Back Better Act is Inevitable

January 11, 2022 Christina Smith

The BBBA is more big government socialism, with a price tag of $4.9 trillion over 10 years.

Price Controls Will Create an Invisible Graveyard of Americans
Big Government, Biopharmaceuticals, CMS, General Waste, Healthcare, Medicaid, Medicare, Medicare/aid, Pharmaceuticals

Price Controls Will Create an Invisible Graveyard of Americans

December 18, 2021 Christina Smith

The Build Back Better Act will cost lives by devastating the development of future cures.

Citizens Against Government Waste Releases Analysis of Minnesota Opioid Tax
340B, General Waste, Government Waste, Healthcare, Oversight, Pharmaceuticals

New Study Confirms 340B Program is Exploited

December 3, 2021 Elizabeth Wright

A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.

Posts pagination

Previous 1 2 3 4 Next

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • MISSION/HISTORY
  • DIRRECTORS/STAFF
  • SUPPORT
  • FINANCIAL INFORMATION
  • CONTACT US
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste